Enterprise Products EVP and Chief Commercial Officer Brent Secrest resigns effective May 1, 2025

ENTERPRISE PRODUCTS PARTNERS L.P.

Brent B. Secrest resigned as EVP and Chief Commercial Officer of the general partner, effective May 1, 2025.
No replacement has been announced for Secrest's role.
Partnership and Secrest remain in discussions regarding terms of his departure.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brent B. Secrest

Executive Vice President and Chief Commercial Officer

EPD · ENTERPRISE PRODUCTS PARTNERS L.P.

Effective: 2025-05-01
Filed: April 22, 2025, 7:59 PM ET

On April 21, 2025, Brent B. Secrest tendered his resignation as Executive Vice President and Chief Commercial Officer of Enterprise Products Holdings LLC, the general partner (the “Enterprise GP”) of Enterprise Products Partners L.P. (the “Partnership”), with such resignation to take effect as of May 1, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brent B. Secrest resigned as Executive Vice President and Chief Commercial Officer at ENTERPRISE PRODUCTS PARTNERS L.P..

Action: resigned
Role: Executive Vice President and Chief Commercial Officer

Exact text from the filing

On April 21, 2025, Brent B. Secrest tendered his resignation as Executive Vice President and Chief Commercial Officer of Enterprise Products Holdings LLC, the general partner (the “Enterprise GP”) of Enterprise Products Partners L.P. (the “Partnership”), with such resignation to take effect as of May 1, 2025.

View on SEC.gov

ENTERPRISE PRODUCTS PARTNERS L.P. filing history →

Source: SEC EDGAR

accession 0001193125-25-087903

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.